Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

4976 Seviteronel
74252bdc1a81c3274716ce17a84763673e31bfa4d6d32730d354bcbe14cd006f

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Seviteronel (developmental codes VT-464 and, formerly, INO-464) is an experimental cancer medication which is under development by Viamet Pharmaceuticals and Innocrin Pharmaceuticals for the treatment of prostate cancer and breast cancer. It is a nonsteroidal CYP17A1 inhibitor and works by inhibiting the production of androgens and estrogens in the body. As of July 2017, seviteronel is in phase II clinical trials for both prostate cancer and breast cancer. In January 2016, it was designated fast-track status by the United States Food and Drug Administration for prostate cancer. In April 2017, seviteronel received fast-track designation for breast cancer as well.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
4975 Next ≫
4977
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan